Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the worl…
An institutional-grade, numbers-driven thesis on COR — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of August 8, 2026, TradersQuant's model rates Cencora Inc (COR) 60/100 with a 12-month base-case forecast of $367.82 — +14.8% versus the current price of $320.46. Cencora Inc trades at $320.46 in the Health Care sector, with a market capitalisation of $61.15B. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month TradersQuant model price target for COR is $367.82, implying +14.8% versus the current price. The model's 12-month scenario range runs from $345.24 (bear) to $412.78 (bull), with a base case of $367.82.
On the fundamentals, Cencora shows a P/E of 23.3, trailing revenue of $333.83B, revenue growth of +5.1% YoY, a dividend yield of 0.74%. This page also tracks COR's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
COR currently carries a TradersQuant composite score of 60/100, which we read as a neutral-to-watch signal. The Wall-Street analyst consensus is "buy". Our 12-month price target of $367.82 implies +14.8% from $320.46. This is research, not financial advice — always combine it with your own judgement.
The TradersQuant 12-month model price target for COR is $367.82, about +14.8% versus the latest price of $320.46. Consensus is based on 20 analysts.
TradersQuant's 12-month model forecast for COR is a base case of $367.82, ranging from $345.24 (bear) to $412.78 (bull), an expected return of +14.8%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for COR over the next 12 months is $367.82 in the base case (bear $345.24, bull $412.78), versus today's price of $320.46. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for COR — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates COR's fair value at $417.08, implying +30.1% of expected upside versus the current price.
Yes — Cencora pays a dividend yielding 0.74% (about $2.37 per share annually).
Data and model outputs are for research only and are not financial advice. Figures update continuously.
